Biorce secured 52.5 million USD in Series A funding to scale Aika, an AI platform that generates reg...
The AMW Read
The article reports a standard Series A funding round for a new entrant in the AI-driven clinical trial protocol space, which is an incremental update to the vertical AI healthcare landscape.
NoveltySignificance
Healthcare & Bio · Player Map
Biorce secured 52.5 million USD in Series A funding to scale Aika, an AI platform that generates regulator ready protocols in 90 seconds. Leveraging one million historical trials, it aims to cut drug development timelines by 50 percent. This record investment supports expansion to Austin, targeting 120 billion USD in annual inefficiencies. Predictive AI is now a systemic benchmark for oncology and rare disease research. 🚀
